Director, HCP Marketing - DM1

Responsibilities

• Own HCP strategy and execution for DM1 from pre-launch through launch and beyond
• Define HCP segmentation and map priority behaviors across stages of adoption
• Translate clinical data and labels into HCP message strategy and content priorities
• Own the HCP omnichannel engagement strategy across personal and non-personal promotion
• Build closed-loop deployment models to test and optimize messaging and channels
• Partner with Medical, Scientific Affairs, Market Access, and Field Teams to ensure cohesive HCP experience
• Lead peer-to-peer education strategy and execution using modern formats
• Own end-to-end commercial congress strategy including messaging, content, and booth experience
• Drive PRC execution for HCP materials to ensure regulatory and compliance alignment

Requirements

• Bachelor’s degree required
• 10+ years of experience in pharmaceutical or biotechnology marketing
• 5+ years of experience in US HCP Marketing
• Demonstrated success leading launch-phase HCP marketing for specialty or rare disease products
• Proven ability to translate complex science into compelling, compliant HCP messaging
• Willingness to travel up to 30%

Preferred Qualifications

• Advanced degree such as MBA or MPH
• Experience in neurology, neuromuscular, rare disease, or accelerated approval
• Experience working in fast-paced, cross-functional environments
• Early adopter of emerging technologies and AI-enabled marketing solutions

About the Company

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for FSHD and Pompe disease.